Study details
Enrolling now
Autonomic Control of the Circulation and VDR
Milton S. Hershey Medical Center
NCT IDNCT03513770ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
18
Study length
about 6.8 years
Ages
21–35
Locations
1 site in PA
About this study
Researchers are testing how the body's autonomic nervous system responds to blood vessel distension. The trial will examine if a medication called ketorolac can change this response, potentially by affecting nerve activity in the legs.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take ketorolac tromethamine
- 2.Take saline control
- 3.Wrist-to-elbow (W-E) occlusion
PhaseEARLY_Phase 1
Drugketorolac tromethamine
Routeoral
Primary goalVein size with MRI
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
Analgesics (Cyclooxygenase Inhibitors)
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Vein size with MRI
Secondary: Blood Pressure, Heart Rate